Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders

Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders

US Patent 12370139 · Granted Jul 29, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment of polycystic kidney disease2025
Edaravone salt2021
Edaravone salt2021
Medical treatment comprising enteral administration of edaravone2021